chrisvoncsefalvay/vaers-outcomes huggingface dataset:
body ache; Loose hair; chills; fever; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 06Mar2021 12:00 (Lot number: EL9269) at the age of 68 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "asthma" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing); "known allergies: Iodine" (unspecified if ongoing), notes: known allergies: Iodine; "Covid-19" (unspecified if ongoing). Concomitant medication(s) included: TOPROL XL; TRIAMTERENE. The following information was reported: PAIN (non-serious) with onset 01Jun2021 12:00, outcome "recovering", described as "body ache"; ALOPECIA (non-serious) with onset 01Jun2021 12:00, outcome "recovering", described as "Loose hair"; CHILLS (non-serious) with onset 01Jun2021 12:00, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 01Jun2021 12:00, outcome "recovering", described as "fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, alopecia, chills, pyrexia.  Additional information included: The patient received other Pfizer vaccine on 06Mar2021, lot number: ER8730, dose 1, in left arm. The patient did not receive any other vaccine with in four weeks. The patient was diagnosed with covid prior vaccination. The patient was tested with covid-19 post vaccination. Covid test type post vaccination: Nasal Swab. Covid test result: Negative. Covid test date: 01Apr2021. Device Date: 29Nov2021.   No follow-up attempts are possible. No further information is expected.
patient reported that the injection site was puffy, red, hot/inflammed, and swelled up to the size of her hand and remained like that throughout the weekend, patient reported that the swelling went down today and the color is returning to normal but hasn't gotten to baseline yet.
PATIENT RECEIVED 1ST DOSE PFIZER AT ANOTHER LOCATION, CAME TO OUR PHARMACY TO GET THE 2ND DOSE, BUT I ADMINISTERED MODERNA INSTEAD OF PFIZER FOR HIM. I HAD HIM MONITORED AT PHARMACY FOR 15 MINUTES AND HE WAS FINE. I CALLED A FEW HOURS AFTER THE VACCINATION WHEN I REALIZED I HAD GIVEN HIM THE WRONG MRNA VACCINE AND HE VERIFIED THAT HE WAS FINE AND WANTED TO KNOW WHETHER HE HAD TO RESTART THE SERIES, AND I CONFIRMED HE DOES NOT.
Information has been received from a consumer reading on the internet concerning a female who on an unspecified date was vaccinated with the first dose of GARDASIL vaccine (yeast). The patient was vaccinated with the second dose of GARDASIL vaccine (yeast) on an unspecified date. The patient became depressed after receiving the first dose and recovered shortly afterward. After receiving her second dose she became even more depressed. This is one of several reports from the same source. No further information is available.
Information has been received from a female consumer with no medical history or allergies who on 06-FEB-2007 was vaccinated with a dose of Zostavax. Concomitant therapy included lovastatin (manufacturer unknown) and lisinopril (manufacturer unknown). On approximately 09-FEB-2007 "three days after vaccination" the patient developed rashes on both legs. The patient reported that the rashes were itchy and had "red ring around i and rashes had lasted for 3 weeks and then disappeared and went back again". No diagnostic laboratory tests were undertaken. At the time of report the patient was not recovered. A product quality complaint was not involved. No further information is available.
Covid 19 positive; Covid 19 positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 47-year-old male patient received BNT162b2 (BNT162B2), on 18Feb2021 as dose 1, single (Lot number: EL19266), on 10Mar2021 as dose 2, single (Lot number: EN6206) and on 27Oct2021 as dose 3 (booster), single (Lot number: EH8020) at the age of 47 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Jul2022, outcome "not recovered" and all described as "Covid 19 positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Jul2022) Positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  Clinical course: Other medication in 2weeks was reported as no. If other vaccine in four weeks was reported as no. If COVID prior vaccination was reported as no. If COVID tested post vaccination was reported as yes. If treatment AE was reported as no.  No follow-up attempts are possible. No further information is expected.
hot flashes, faint & dizzy; loss of consciousness x approx 20-25cc;
Following administration of vaccine, patient was sat in a chair in pharmacy counsel room, and fainted.  Vaccine was administered by a pharmacy intern, and stated that he was unconscious and convulsing and bumped his head on the wall that he was sat adjacent too.  Pharmacy manager attended to patient, and he had already regained consciousness.  No visible injury to head and blood pressure was monitored and was 115/73 with a pulse of 66.  Patient was given water to drink and offered a  gatorade, plus a snack, and monitored for another 15 minutes.  Patient stated that he was feeling better and ha no other complaints or reported any injury nor pain to the head. Mother was present  the whole time and did not have any additional concerns or requests for additional medical attention.
This spontaneous report as received from a Registered Nurse refers to a male patient of unknown age. The nurse stated that the patient was vaccinated with the first dose of GARDASIL, injection, intramuscularly, dose 0.5 ml (lot number and exp. date not reported) on 13-AUG-2012 and second dose GARDASIL injection, intramuscularly, dose 0.5 ml (lot number and exp. date not reported) on 12-AUG-2013. No adverse event was reported. The outcome of events was unknown. Additional information is not expected.
suspected vaccination failure/ suspected vaccination failure; shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received shingle shot and was told it was a 1 time thing you had to get, later patient got the shingles. The doctor said well if you hadn't got the shot they could have been worse. The patient stated that it seems to her/him someone is making tons of money. The follow up would not be possible as no contact details were available. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule and time to onset and laboratory confirmation for shingles were unknown.
Information has been received concerning a male diagnosed with mononucleosis (early 2001) who on 05-NOV-2001 was vaccinated with a dose of RECOMBIVAX HB (manufacturer unknown). Two doctors retained by the petitioners opined that the patient had recovered from the Epstein Barre infection before the 05-NOV-2001, hepatitis B vaccination in question, while two doctors retained by the respondent opined the patient continued to show signs of Epstein Barr infection for months later. His mother testified that he experienced certain problems the evening he received the vaccine, but she did not consult a doctor. No contemporaneous medical record supported the mother's descriptions of his problems. He went to the emergency room on 03-NOV-2001, where doctors eventually diagnosed him with vestibular neuronitis. In early 2002, he complained of fatigue and he was eventually diagnosed with chronic fatigue syndrome. Additional information has been requested.
day of vax pt became pale/faint c/o numbness/tingling to rt side of face & rt arm. elev BP
late evening on 2OCT97 felt like running fever, rt arm inc red, swollen, hot to touch over 3/4 of upper arm;still hot swollen & red on 3OCT97;recommended cool packs for 10min @ a time off & on rest of day;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 04-JAN-2016, the patient was inoculated with ZOSTAVAX at a clinic as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 02-AUG-2016, the patient was treated at a medical center for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. The patient was prescribed VALTREX for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
My son received only 1 shot, soon after he started having chest pain, he went to the hospital and was diagnosed with pericarditis and pleurisy. His care has been ongoing since the vaccine, he did NOT get the 2nd dose...obviously. Most recently he's been diagnosed with nerve damage to his heart. I do not have all of the exact info, but he does, and I'm sure you could obtain it.
I caught covid. I tested positive on August 11, 2021. I am mostly getting back to normal now, but my smell is still off a bit. The lady who called me from VAERS said to fill this out but most of this seems to be for immediate reactions rather than for reporting breakthrough cases.
received a dose of the Fluzone High-Dose Quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event; received a dose of the Fluzone High-Dose Quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event; Initial information received on 30-Aug-2022 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 72 years old male patient who reported received a dose of the fluzone high-dose quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event while receiving vaccine influenza quadrival a-b high dose hv vaccine (Fluzone High-Dose Quadrivalent).  Concomitant medications: shingles vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 29-Aug-2022, the patient received a dose of suspect influenza quadrival a-b high dose hv vaccine via prefilled syringe at a dose of 0.7 ml with lot UJ904AB and expiry date: 30-Jun-2023 via intramuscular route in right arm for Immunization.  On 29-Aug-2022 (latency: same day) the patient developed a non-serious received a dose of the fluzone high-dose quadrivalent before they found out that the vaccine needed to be quarantined with no reported adverse event (product storage error) and (product administration error) following the administration of influenza quadrival a-b high dose hv vaccine.  Action taken: not applicable  Outcome: unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report was received from a nurse, referring to a currently 13-year-old female patient. The patient's medical history, concomitant medications and concurrent conditions were not disclosed. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 single 0.5ml dose (anatomical injection site, route of administration, and indication not disclosed), lot # R022249 and expiration date 16-APR-2020. It was reported that this vaccine had been on a temperature excursion and was stored at or above 32 °F up to 35 °F (0°C to 1°C) (32.5F) during 8 hours; but it was also noted that there had not been a previous temperature excursion. At the time of this report, there were no adverse events reported. Digital data logger was involved. This was one of two cases received from the same reporter.; Sender's Comments: US-009507513-1812USA008680:
terrible headache; Very tired; very weak; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (terrible headache), FATIGUE (Very tired) and ASTHENIA (very weak) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025JZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HEADACHE (terrible headache), FATIGUE (Very tired) and ASTHENIA (very weak). The patient was treated with PARACETAMOL (TYLENOL) on 20-Jan-2021 at an unspecified dose and frequency. At the time of the report, HEADACHE (terrible headache), FATIGUE (Very tired) and ASTHENIA (very weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the events, a causal relationship cannot be excluded.
This spontaneous report was received from a registered nurse concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with a dose of GARDASIL 9 injection, lot number L037554; expiration date 25-DEC-2017 or lot number N001533; expiration date 16-OCT-2019 or lot number M042853; expiration date 17-JUL-2019 (strength, dose and route of administration were not reported) for prophylaxis. The temperature of excursion with the GARDASIL 9 was between 47 to 77 Fahrenheit degrees during 5 hours. Previous temperature excursion was between 47 to 77 Fahrenheit degrees during 6 hours. The temperature of excursion was detected by a data logger. No adverse effects reported. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1707USA006406: US-009507513-1707USA006407.
PT received 2 vaccines on left arm on 10/21/2020 and on 10/22/2020 PT had redness / swelling on his left arm and was given antibiotics.
Approximately 2 weeks after receiving Lymerix #2, the patient developed an ache in her arm at the injection site.  The pain worsened and spread up her left arm to her shoulder and neck. The pain increased, and now the patient has pain in all her joints and muscles. This problem has not been helped by treatment with Prednisone, muscle relaxants, or anti-inflammatory medications.
This spontaneous report as received from a pharmacist refers to a 59 year old male patient (also reported as 57 years old). No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 08-OCT-2016, the patient was vaccinated with ZOSTAVAX (which had a lot # of M020071 with an expiration date of 18-JUL-2017), subcutaneously, (the dose and dosage number were unknown). No concomitant therapies were reported. Subsequently, on 10-OCT-2016, the patient experienced swelling, redness, warmth, and tenderness at the injection site. No treatment was provided for the events and no product quality complaint was involved. At the time of reporting, it was believed that the events remained unsolved. The reporter failed to provide any explicit causal relationship between the events and the vaccination with ZOSTAVAX. Additional information has been requested.
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies were not provided. On 28-OCT-2013, the patient was vaccinated with a first dose of ROTATEQ, orally, (Lot number not provided), which expired on 27-OCT-2013. Co-suspect therapies and concomitant medications were not provided. No adverse events were reported. Additional information has been requested.
facial numbness; right side of the face tingling; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (facial numbness) and PARAESTHESIA (right side of the face tingling) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine headache.    On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jun-2021, the patient experienced HYPOAESTHESIA (facial numbness) and PARAESTHESIA (right side of the face tingling). At the time of the report, HYPOAESTHESIA (facial numbness) and PARAESTHESIA (right side of the face tingling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was reported.
Approximately 10 minutes after receiving the vaccine the patient became clammy and light headed. VS were stable and patient stayed an extra 30 minutes until she started feeling better. With follow up call, patient stated that she has headache, nausea and fatigue
Pt states her arm became "itchy, red, and warm" after her 1st dose & 4th dose of Moderna COVID-19 vaccine. She said it appeared next day & lasted several days to a week.
patient came to clinic to get the vaccine and she did not bring her shot record, she was told the last office visit that she had to come in one month for the second dose. our system was not working, we were not able to log in to our system to see her shot record. but like patient needed the vaccine to go to college she just wanted to get and was demanding it. We just want to see if patient can have any side affects to do that she got a second Men B within one week. we spoke to patient and told her that we go on a protocol based vaccines.
Headache, fatigue, injection site pain after second dose; Headache, fatigue, injection site pain after second dose; Headache, fatigue, injection site pain after second dose; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient (Non pregnant)  received bnt162b2 (BNT162B2, Formulation:Solution for injection, Batch/Lot Number: EL3247) , dose 2 via an unspecified route of administration, administered in left arm on 17Feb2021 at 10:30 am as  a single dose for (at the age of 50 year) Covid-19 immunisation at Workplace clinic. The patient medical history and concomitant medications were not reported. No known allergies.  The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine and received other medications in two weeks include birth control pills.  Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19.  Historical vaccine include  bnt162b2 (BNT162B2,Formulation: Solution for injection Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in left arm on 27Jan2021, at 12:15 pm as  a single dose for (at the age of 50 year)  Covid-19 immunisation at Workplace clinic and experienced Enlarged lymph nodes on left side (vaccination side) in recent mammogram on 16Feb2021 after first dose. The patient experienced, headache, fatigue, injection site pain after second dose on 17Feb2021. Treatment not received for the events. Outcome of the event was unknown.  .  No follow up attempts are possible. No further information is expected.
Headache and fatigue beginning the evening of March 13th, Early the morning of the 14th, woke to  myalgias and body aches.   Low grade fever.  Swollen lymph node in right shoulder.  Some relief with Motrin.
Had vaccine , shingles in 2017\ Suspected vaccination failure; Shingles in 2017, still have probalem; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles vaccine and shingles in 2017 still had problem. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Fever - 101, pain to entire arm, malaise, myalgias, radiculoneuropathy, erythema, sore and puffy (R) upper arm.
The day after, barely able to get up to even pee (passed out on floor that night, took hurculean effort next day to not pee on the floor where I laid). Moderate to severe pain in upper left arm at first, progressed to soreness up into shoulder and down to elbow over next couple weeks. Upper left arm numb for a few days, then soreness and achiness present to this day. It gets worse with increased use (daily activity) and hurts to exercise (weights, pushups, etc). It's been almost 6 months. I've never had a shot that hurt for more than a couple days. I've given natural birth without drugs twice and it didn't hurt this long after like this shot has.
Moderate to severe flu like symptoms (fever, ache, headache, chills, extremely tired, sleepy, couldn't concentrate. This lasted for 2.5 days, Did not have a sore throat or cough.
I lost my appetite and have lost 12 pounds since my first vaccine. Weeks after the second I have had a bunch of strange things happen. I have done yoga for decades and never have had any problem sitting cross legged - but now my knees are too sore and my legs hurt.. my palms have turned red.. and I almost swooned into unconsciousness a few days ago- you can say I am just old- but I never had sore legs. swollen knees, red palms, and dizziness before in my life.  I think I might hesitate to get the second shot if I* had it to do over again